Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jul 7;10(43):25557-25566.
doi: 10.1039/d0ra02574g. eCollection 2020 Jul 3.

Efficient modification of PAMAM G1 dendrimer surface with β-cyclodextrin units by CuAAC: impact on the water solubility and cytotoxicity

Affiliations

Efficient modification of PAMAM G1 dendrimer surface with β-cyclodextrin units by CuAAC: impact on the water solubility and cytotoxicity

Kendra Sorroza-Martínez et al. RSC Adv. .

Abstract

The toxicity of the poly(amidoamine) dendrimers (PAMAM) caused by the peripheral amino groups has been a limitation for their use as drug carriers in clinical applications. In this work, we completely modified the periphery of PAMAM dendrimer generation 1 (PAMAM G1) with β-cyclodextrin (β-CD) units through the Cu(i)-catalyzed azide-alkyne cycloaddition (CuAAC) to obtain the PAMAM G1-β-CD dendrimer with high yield. The PAMAM G1-β-CD was characterized by 1H- and 13C-NMR and mass spectrometry studies. Moreover, the PAMAM G1-β-CD dendrimer showed remarkably higher water solubility than native β-CD. Finally, we studied the toxicity of PAMAM G1-β-CD dendrimer in four different cell lines, human breast cancer cells (MCF-7 and MDA-MB-231), human cervical adenocarcinoma cancer cells (HeLa) and pig kidney epithelial cells (LLC-PK1). The PAMAM G1-β-CD dendrimer did not present any cytotoxicity in cell lines tested which shows the potentiality of this new class of dendrimers.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Scheme 1
Scheme 1. Synthesis of alkynyl-PAMAM G1. Conditions: (i) propargyl bromide, K2CO3, anhydrous acetone, 24 h, reflux; (ii) NaOH/HCl, EtOH : H2O; (iii) EDC, HOBt, DIPEA, DMF, 35 °C, 5 days.
Scheme 2
Scheme 2. Synthesis of m-N3-β-CD. Conditions: (i) TsO2/NaOH, H2O, 2 h, RT; (ii) NaN3, DMF, 80 °C, 48 h.
Scheme 3
Scheme 3. Synthesis of PAMAM G1-β-CD. Conditions: “Click” CuSO4·5H2O, H2Asc, DMSO, 80 °C, 48 h.
Fig. 1
Fig. 1. 1H NMR spectrum of PAMAM G1-β-CD in DMSO-d6.
Fig. 2
Fig. 2. Cell viability in different cell lines of PAMAM G1-β-CD dendrimer. The treated cells were cultured in six wells by concentration, and the experiments were performed three times independently. Data are means ± S.D.

References

    1. Sharma A. K. Gothwal A. Kesharwani P. Alsaab H. Iyer A. K. Gupta U. Drug Discovery Today. 2017;22:314. doi: 10.1016/j.drudis.2016.09.013. - DOI - PubMed
    1. Caminade A. M. Chem. Commun. 2017;53:9830. doi: 10.1039/C7CC04949H. - DOI - PubMed
    1. Nanjwade B. K. Bechra H. M. Derkar G. K. Manvi F. V. Nanjwade V. K. Eur. J. Pharm. Sci. 2009;38:185. doi: 10.1016/j.ejps.2009.07.008. - DOI - PubMed
    1. Diaz C. Benitez C. Vidal F. Barraza L. F. Jiménez V. A. Guzman L. Fuentealba J. Yevenes G. E. Alderete J. B. Nanomedicine. 2018;14:2227. doi: 10.1016/j.nano.2018.07.005. - DOI - PubMed
    1. Tomalia D. A. Prog. Polym. Sci. 2005;30:294. doi: 10.1016/j.progpolymsci.2005.01.007. - DOI